Search results for "Theranostics"

showing 10 items of 26 documents

Development of fluorescent platforms for the design of multifunctional compounds for in vitro and in vivo applications in molecular imaging

2018

The objective of this thesis was the development and evaluation of new molecular platformsfor optical fluorescence imaging applications. This work sought to develop new tools that caneasily be modified and adapted to the specific needs of the intended use. This is required asthe fluorophore will influence the final properties and should thus be incorporated beforestructural optimization of the selected agent rather than at the very end. Two main axes wereexplored; the use of BODIPYs for the development of trackable therapeutic agents that areprimarily intended for in vitro applications and the use of azaBODIPYs for the design of an invivo compatible fluorescent platform.In the first part tw…

AzaBODIPYTraçable[SPI.OPTI] Engineering Sciences [physics]/Optics / PhotonicImagerieBodipyTrackable[SPI.OPTI]Engineering Sciences [physics]/Optics / PhotonicTheranostiqueTheranosticsFluorescenceImaging
researchProduct

Terbium Medical Radioisotope Production: Laser Resonance Ionization Scheme Development

2021

Terbium (Tb) is a promising element for the theranostic approach in nuclear medicine. The new CERN-MEDICIS facility aims for production of its medical radioisotopes to support related R&D projects in biomedicine. The use of laser resonance ionization is essential to provide radioisotopic yields of highest quantity and quality, specifically regarding purity. This paper presents the results of preparation and characterization of a suitable two-step laser resonance ionization process for Tb. By resonance excitation via an auto-ionizing level, the high ionization efficiency of 53% was achieved. To simulate realistic production conditions for Tb radioisotopes, the influence of a surplus of Gd at…

Medicine (General)theranosticsMaterials scienceCERN-MEDICISIon beam530 PhysicsGadolinium610 Medizinchemistry.chemical_elementTerbiumTERBIUMSURFACE PROPERTYIsotope separationlaw.inventionGADOLINIUMR5-920COMPARATIVE STUDYlawIonization610 Medical sciencesLASER RESONANCE IONIZATIONSAPPHIRE LASER [TI]ARTICLERADIOCHEMISTRYisotope separationTANTALUMOriginal ResearchTHERANOSTICSTi:Sapphire laserRISIKO MASS SEPARATORterbiumATOMIC SPECTROMETRYRadiochemistryTi:sapphire laserGeneral Medicine530 PhysikCharacterization (materials science)CONTROLLED STUDYchemistryRISIKO mass separatorION CURRENTMedicineISOTOPE SEPARATIONIONIZATIONAtomic ratiolaser resonance ionizationgadolinium
researchProduct

Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer

2017

Background: Various trivalent radiometals are well suited for labeling of DOTA-conjugated variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The DOTA-conjugate PSMA-617 has proven high potential in PSMA radioligand therapy (PSMA-RLT) of prostate cancer as well as PET imaging when labeled with lutetium-177 and gallium-68 respectively. Considering the relatively short physical half-life of gallium-68 this positron emitter precludes prolonged acquisition periods, as required for pre-therapeutic dosimetry or intraoperative applications. In this context, the positron emitter scandium-44 is an attractive alternative for PET imaging. We report the synthesis of [44Sc…

OncologyMalemedicine.medical_specialtytheranostics.Medicine (miscellaneous)Context (language use)SpleenGallium RadioisotopesLutetiumurologic and male genital diseases030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancerHeterocyclic Compounds 1-Ring0302 clinical medicineInternal medicinePositron Emission Tomography Computed TomographyLNCaPmedicineDosimetryHumansRadiometryPharmacology Toxicology and Pharmaceutics (miscellaneous)AgedRadioisotopesUrinary bladderChemistrybusiness.industryDipeptidesProstate-Specific Antigenmedicine.diseaseprostate cancerPSMA-617scandium-44Small intestineProstatic Neoplasms Castration-Resistantmedicine.anatomical_structurePET030220 oncology & carcinogenesisAbsorbed doseRadiopharmaceuticalsNuclear medicinebusinessScandiumResearch PaperHalf-LifeTheranostics
researchProduct

Extracellular Vesicle-Mediated Cell–Cell Communication in the Nervous System: Focus on Neurological Diseases

2019

Extracellular vesicles (EVs), including exosomes, are membranous particles released by cells into the extracellular space. They are involved in cell differentiation, tissue homeostasis, and organ remodelling in virtually all tissues, including the central nervous system (CNS). They are secreted by a range of cell types and via blood reaching other cells whose functioning they can modify because they transport and deliver active molecules, such as proteins of various types and functions, lipids, DNA, and miRNAs. Since they are relatively easy to isolate, exosomes can be characterized, and their composition elucidated and manipulated by bioengineering techniques. Consequently, exosomes appear…

Nervous systemReviewCell CommunicationTheranostic NanomedicineCatalysilcsh:Chemistry0302 clinical medicineCell–cell interactionlcsh:QH301-705.5Tissue homeostasisSpectroscopyDrug Carriers0303 health sciencesnervous systemCell DifferentiationNeurodegenerative DiseasesComputer Science Applications1707 Computer Vision and Pattern RecognitionGeneral MedicineExtracellular vesicleComputer Science ApplicationsCell biologymedicine.anatomical_structureTheranostics toolExtracellular vesicleextracellular vesiclesneurological diseasesCell signalingCell typecell–cell interactionexosomesBiologyCatalysisInorganic Chemistry03 medical and health sciencesExtracellularmedicineCell-cell interactionHumansPhysical and Theoretical ChemistryMolecular Biology030304 developmental biologytheranostics toolsOrganic ChemistrybiomarkersBiomarkercentral nervous systemMicrovesiclesExosomelcsh:Biology (General)lcsh:QD1-999030217 neurology & neurosurgeryNeurological diseaseInternational Journal of Molecular Sciences
researchProduct

Bone targeting compounds for radiotherapy and imaging: *Me(III)-DOTA conjugates of bisphosphonic acid, pamidronic acid and zoledronic acid

2016

Background Bisphosphonates have a high adsorption on calcified tissues and are commonly used in the treatment of bone disorder diseases. Conjugates of bisphosphonates with macrocyclic chelators open new possibilities in bone targeted radionuclide imaging and therapy. Subsequent to positron emission tomography (PET) examinations utilizing 68Ga-labelled analogues, endoradiotheraphy with 177Lu-labelled macrocyclic bisphosphonates may have a great potential in the treatment of painful skeletal metastases. Methods Based on the established pharmaceuticals pamidronate and zoledronate two new DOTA-α-OH-bisphosphonates, DOTAPAM and DOTAZOL(MM1.MZ) were successfully synthesized. The ligands were labe…

lcsh:Medical physics. Medical radiology. Nuclear medicineBiodistributionMaterials sciencelcsh:R895-920Hydroxy bisphosphonatesSingle-photon emission computed tomography01 natural sciences030218 nuclear medicine & medical imagingAnalytical Chemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePharmacokineticsmedicineDOTAPharmacology (medical)Radiology Nuclear Medicine and imagingZoledronic acidPharmacologymedicine.diagnostic_test010405 organic chemistrybusiness.industryResearchBone metastaseslcsh:RM1-950Pamidronic acid177LuTheranostics68Ga0104 chemical sciencesZoledronic acidPETlcsh:Therapeutics. PharmacologyDOTAchemistryPositron emission tomographyNuclear medicinebusinessEx vivomedicine.drugEJNMMI Radiopharmacy and Chemistry
researchProduct

Computational Analysis of Clinical and Molecular Markers and New Theranostic Possibilities in Primary Open-Angle Glaucoma

2020

Primary open-angle glaucoma (POAG) is a paramount cause of irreversible visual disability worldwide. We focus on identifying clinical and molecular facts that may help elucidating the pathogenic mechanisms of the disease. By using ophthalmological approaches (biomicroscopy, ocular fundus, optical coherence tomography, and perimetry) and experimental tests (enzyme-linked immunosorbent assay (ELISA), high performance liquid chromatography (HPLC), and Western blot/immunoblotting) directed to evaluate the oxidative stress, inflammation, apoptosis, and neurodegeneration processes, we gather information to build a network of data to perform a computational bioinformatics analysis. Our results sho…

Posterior Eye Segmentmedicine.medical_specialtytheranosticsprimary open-angle glaucomaOpen angle glaucomagenetic structuresGlaucomalcsh:MedicineVisual disabilityDiseaseArticlePathogenesis03 medical and health sciences0302 clinical medicineOphthalmologymedicineoxidative stressComputational analysisbusiness.industrypathogenesisNeurodegenerationlcsh:RapoptosisneurodegenerationGeneral Medicinemedicine.diseaseeye diseasesinflammation030221 ophthalmology & optometrysense organsbusiness030217 neurology & neurosurgeryJournal of Clinical Medicine
researchProduct

Carbon Nanodots as Functional Excipient to Develop Highly Stable and Smart PLGA Nanoparticles Useful in Cancer Theranostics

2020

Theranostic systems have attracted considerable attention for their multifunctional approach to cancer. Among these, carbon nanodots (CDs) emerged as luminescent nanomaterials due to their exceptional chemical properties, synthetic ease, biocompatibility, and for their photothermal and fluorescent properties useful in cancer photothermal therapy. However, premature renal excretion due to the small size of these particles limits their biomedical application. To overcome these limitations, here, hybrid poly(lactic-co-glycolic acid) (PLGA-CDs) nanoparticles with suitable size distribution and stability have been developed. CDs were decisive in the preparation of polymeric nanoparticles, not on…

Fluorescence-lifetime imaging microscopyphotothermal therapyBiocompatibilitylcsh:RS1-441Pharmaceutical ScienceExcipientNanoparticleNanotechnology02 engineering and technology010402 general chemistry01 natural sciencesArticleNanomaterialslcsh:Pharmacy and materia medicahybrid nanoparticleschemistry.chemical_compoundcarbon nanodotmedicinecarbon nanodotsViability assaycancer theranosticChemistryhybrid nanoparticlePLGAimagingPhotothermal therapy021001 nanoscience & nanotechnology0104 chemical sciencesPLGASettore CHIM/09 - Farmaceutico Tecnologico Applicativocancer theranostics0210 nano-technologymedicine.drugPharmaceutics
researchProduct

Carbon Nanodots for On Demand Chemophotothermal Therapy Combination to Elicit Necroptosis: Overcoming Apoptosis Resistance in Breast Cancer Cell Lines

2020

Background: Engineered luminescent carbon nanodots (CDs) are appealing nanomaterials for cancer image-guided photothermal therapy combining near infrared (NIR)&ndash

0301 basic medicineCancer ResearchtheranosticsNecroptosisanticancer phototherapynecroptosisSettore BIO/11 - Biologia Molecolare02 engineering and technologylcsh:RC254-282Article03 medical and health sciencesRIPK1breast cancermedicineirinotecan;carbon nanodotsirinotecanChemistrygene expression analysesCancerPhotothermal therapy021001 nanoscience & nanotechnologymedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensIrinotecan030104 developmental biologyOncologySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoApoptosisDrug deliveryCancer cellCancer research0210 nano-technologymedicine.drugCancers
researchProduct

On the Choice of the Extracellular Vesicles for Therapeutic Purposes

2019

Extracellular vesicles (EVs) are lipid membrane vesicles released by all human cells and are widely recognized to be involved in many cellular processes, both in physiological and pathological conditions. They are mediators of cell-cell communication, at both paracrine and systemic levels, and therefore they are active players in cell differentiation, tissue homeostasis, and organ remodeling. Due to their ability to serve as a cargo for proteins, lipids, and nucleic acids, which often reflects the cellular source, they should be considered the future of the natural nanodelivery of bio-compounds. To date, natural nanovesicles, such as exosomes, have been shown to represent a source of diseas…

theranosticsregenerative medicineReviewexosomesBiologyRegenerative medicineExtracellular vesiclesCatalysisTheranostic NanomedicineCatalysiInorganic Chemistrylcsh:Chemistry03 medical and health sciencesParacrine signallingExtracellular Vesicles0302 clinical medicineDrug Delivery SystemsNeoplasmsAnimalsHumansPhysical and Theoretical ChemistryLipid bilayerMolecular Biologylcsh:QH301-705.5Tissue homeostasisSpectroscopy030304 developmental biology0303 health sciencesDrug CarriersVesicleOrganic ChemistrybiomarkersComputer Science Applications1707 Computer Vision and Pattern RecognitionBiological TransportGeneral MedicineBiomarkerMicrovesiclesnanodelivery3. Good healthComputer Science ApplicationsCell biologyExosomeTheranosticlcsh:Biology (General)lcsh:QD1-999030220 oncology & carcinogenesisSignal transductionextracellular vesicles (EVs)Signal TransductionInternational Journal of Molecular Sciences
researchProduct

Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery.

2015

BACKGROUND: Heat shock protein 60 (Hsp60) is a chaperonin involved in tumorigenesis, but its participation in tumor development and progression is not well understood and its value as a tumor biomarker has not been fully elucidated. In the current study, the authors presented evidence supporting the theory that Hsp60 has potential as a biomarker as well as a therapeutic target in patients with large bowel cancer. METHODS: The authors studied a population of 97 subjects, including patients and controls. Immunomorphology, Western blot analysis, and quantitative real-time polymerase chain reaction were performed on tissue specimens. Exosomes were isolated from blood and characterized by electr…

MaleCancer ResearchMacrophageBlotting WesternNatural killer cellEnzyme-Linked Immunosorbent AssayAdenocarcinomaExosomesReal-Time Polymerase Chain ReactionMitochondrial ProteinsHeat shock protein 60 (Hsp60)Biomarkers TumorHumansColon adenocarcinomaAgedColon adenocarcinoma; Exosomes; Heat shock protein 60 (Hsp60); Macrophages; Natural killer cells; Plasma cell membrane; Theranostics; Cancer Research; OncologyAged 80 and overPlasma cell membraneChaperonin 60Middle AgedImmunohistochemistryExosomeTheranosticOncologyColonic NeoplasmsFemaleCancer
researchProduct